Detailed Information
Cited 4 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Ramucirumab (RAM) as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline alpha-fetoprotein (AFP): An analysis of AFP kinetics in the phase III REACH-2 study.
- Authors
- Finn, Richard S.; Kudo, Masatoshi; Kang, Yoon-Koo; Yen, Chia-Jui; Galle, Peter R.; Llovet, Josep; Assenat, Eric; Brandi, Giovanni; Lim, Ho Yeong; Pracht, Marc; Rau, Kun Ming; Merle, Philippe; Motomura, Kenta; Ohno, Izumi; Daniele, Bruno; Shin, Dongbok; Gerken, Guido; Abada, Paolo; Hsu, Yanzhi; Zhu, Andrew X.
- Issue Date
- 1-Feb-2019
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.37, no.4
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 37
- Number
- 4
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.